Welcome to LookChem.com Sign In|Join Free

CAS

  • or

102169-44-8

Post Buying Request

102169-44-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102169-44-8 Usage

General Description

4-Bromo-5-methylbenzene-1,2-diamine is a chemical compound that belongs to the class of benzene derivatives with the molecular formula C7H9BrN2. It is also known by the trade name Bronopol and is commonly used as a preservative and antimicrobial agent in personal care products and industrial applications. 4-Bromo-5-methylbenzene-1,2-diamine has a wide range of antimicrobial activity and is effective against bacteria, fungi, and yeasts. It works by disrupting the cell membrane and inhibiting the growth and reproduction of microorganisms. However, it is important to handle this chemical with caution as it has been associated with skin irritation and allergic reactions in some individuals.

Check Digit Verification of cas no

The CAS Registry Mumber 102169-44-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,1,6 and 9 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 102169-44:
(8*1)+(7*0)+(6*2)+(5*1)+(4*6)+(3*9)+(2*4)+(1*4)=88
88 % 10 = 8
So 102169-44-8 is a valid CAS Registry Number.

102169-44-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Bromo-5-methylbenzene-1,2-diamine

1.2 Other means of identification

Product number -
Other names 4-Bromo-5-methyl-benzene-1,2-diamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102169-44-8 SDS

102169-44-8Relevant articles and documents

Benzo[c][1,2,5]thiadiazole Donor-Acceptor Dyes: A Synthetic, Spectroscopic, and Computational Study

Barnsley, Jonathan E.,Shillito, Georgina E.,Larsen, Christopher B.,Van Der Salm, Holly,Wang, Lei E.,Lucas, Nigel T.,Gordon, Keith C.

, p. 1853 - 1866 (2016/04/08)

The synthesis, optical characterization and computational modeling of seven benzo[c][1,2,5]thiadiazole (BTD) donor-acceptor dyes are reported. These dyes have been studied using electrochemical analysis, electronic absorption, emission, and Raman and resonance Raman spectroscopies coupled with various density functional theoretical approaches. Crystal structure geometries on a number of these compounds are also reported. The optical spectra are dominated by low energy charge-transfer states; this may be modulated by the coupling between donor and acceptor through variation in donor energy, variation of the donor-acceptor torsion angle, and incorporation of an insulating bridge. These modifications result in a perturbation of the excitation energy for this charge-transfer transition of up to ~2000 cm-1. Emission spectra exhibit significant solvatochromisim, with Lippert-Mataga analysis yielding Δμ between 8 and 33 D. Predicted λmax, ε, and Raman cross sections calculated by M06L, B3LYP, PBE0, M06, CAM-B3LYP, and ωB97XD DFT functionals were compared to experimental results and analyzed using multivariate analysis, which shows that hybrid functionals with 20-27% HF best predict ground state absorption, while long-range corrected functionals best predict molecular polarizabilities.

Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

-

Page/Page column 29, (2010/11/26)

The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating RXR mediated disorders. More particularly, the compounds of the present invention are RXR agonists useful for treating RXR mediated disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 102169-44-8